The ARFGAP2 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from human A-549 lung carcinoma epithelial cells, designed to abolish ARFGAP2 expression. This model enables loss-of-function analysis of ARFGAP2, a GTPase-activating protein for ARF1, critical in COPI-mediated retrograde trafficking between the Golgi and ER. The polyclonal format provides a heterogeneous gene-disrupted pool for population-level functional studies.
The parental A-549 cell line originates from a 58-year-old Caucasian male with lung adenocarcinoma and serves as a widely used model in cancer biology and drug discovery. These epithelial cells are particularly suited for investigating lung cancer pathophysiology, oncogenic signaling, and therapeutic responses. The ARFGAP2 knockout in this background provides a disease-relevant system to study membrane trafficking defects in tumorigenesis.
ARFGAP2 acts as a GTPase-activating protein for ARF1, accelerating GTP hydrolysis to trigger COPI coat disassembly, a prerequisite for vesicular transport and retrieval of ER-resident proteins. It functions downstream of ARF1 and protein kinase C, interacting directly with coatomer subunits (COPA, COPB1), the KDEL receptor, SNARE proteins, and the GEF GBF1. Through these interactions, ARFGAP2 coordinates COPI dynamics with SNARE-mediated fusion, ensuring retrograde trafficking fidelity. Knockout thus disrupts ARF1 cycling, causing COPI coat accumulation, Golgi fragmentation, and impaired secretion.
In A-549 cells, ARFGAP2 loss of function permits dissection of Golgi-ER retrograde transport in lung adenocarcinoma biology. Dysregulated membrane trafficking has been implicated in cancer cell proliferation, migration, invasion, and drug resistance. This knockout model enables investigation of how ARFGAP2-dependent trafficking influences these malignancy-associated processes, and may also shed light on pathogenic mechanisms underlying neurodegenerative disorders linked to Golgi dysfunction.
Researchers can assess ARFGAP2 ablation by Western blotting, examine Golgi morphology using GM130 immunofluorescence, and quantify retrograde transport with the VSVG-ts045 assay. Complementary functional readouts include cell proliferation, migration, and invasion assays, along with transcriptomic profiling by RNA-seq. The polyclonal knockout population is ideal for rescue experiments, chemical screens, and CRISPR-mediated genetic interaction mapping within the ARF signaling and COPI transport pathways. For further technical resources or custom services, contact Ascent Research.
